Austco Healthcare Limited

AHC.ASX

Health Care

Manufacture, service, supply and distribution of Healthcare and communications equipment.

Market Data

Price

$0.220

-0.0%
Market Cap

$82.4M

P/E Ratio

10.8x

EPS

$0.021

Div. Yield

0.00%

52-Week Change

-0.3%

Latest Earnings

Appendix 4D and 1HFY26 Accounts

18 February 2026

Revenue
$48.20
+30.7% YoY
NPAT
$4.70
+61.7% YoY
EPS
$0.01

Austco Healthcare delivered record first-half revenue of $48.2M, up 30.7% driven by recent acquisitions and strong organic growth. EBITDA surged 60% to $8.3M with margins expanding 310bp to 17.1%, while NPAT increased 61.7% to $4.7M. The company maintains a strong balance sheet with $15.2M cash and no debt, positioning it well for continued growth despite not paying dividends. Key points: Record revenue of $48.2M up 30.7% with strong organic growth of 10% in ANZ and 37% in North America; EBITDA margins expanded significantly by 310bp to 17.1% demonstrating operational leverage and scale benefits; Strong cash generation of $9.2M from operations while maintaining debt-free balance sheet with $15.2M cash

Recent Announcements

1 Jun 2026 Guidance Positive

FY26 Trading Update

Austco Healthcare (ASX: AHC) released an FY26 trading update forecasting revenue of $90-95 million (up 11-17% YoY), EBITDA of $14.0-14.6 million, and net profit after tax of $9.0-9.4 million (up 52-58% YoY), supported by strong sales momentum including a major rollout of Pulse Mobile across 180 US hospitals and new contract wins in Australia, New Zealand, and Canada.

18 Feb 2026 Supplementary Positive

Half Year results investor presentation

Austco Healthcare delivered strong 1H-26 results with revenue growing 30.7% to $48.2m and EBITDA surging 60.1% to $8.3m, demonstrating significant operating leverage. The company benefits from structural healthcare digitization tailwinds and maintains a debt-free balance sheet with $15.2m cash and $47.2m unfilled contracted revenue providing earnings visibility. Growth was driven by successful acquisition integration alongside organic expansion, particularly in North America and ANZ. Key points: Strong operating leverage with EBITDA growing 60.1% vs revenue growth of 30.7%; EBITDA margin expansion from 14.0% to 17.1%, demonstrating scale benefits; Debt-free balance sheet with $15.2m cash providing financial flexibility

18 Feb 2026 Supplementary Positive

Half Year results media release

Austco Healthcare delivered record 1H26 results with revenue growing 31% to $48.2 million and EBITDA surging 60% to $8.3 million. The company demonstrated strong operating leverage with EBITDA margins expanding 310 basis points to 17.1%, while maintaining a debt-free balance sheet with $15.2 million cash. The outlook remains positive with $47.2 million in unfilled contracted revenue providing earnings visibility. Key points: Record revenue growth of 30.7% to $48.2 million driven by acquisitions and organic growth; EBITDA margin expansion of 310 basis points to 17.1% demonstrating strong operating leverage; Debt-free balance sheet with $15.2 million cash providing financial flexibility

18 Feb 2026 Actual Results Positive

Appendix 4D and 1HFY26 Accounts

Austco Healthcare delivered record first-half revenue of $48.2M, up 30.7% driven by recent acquisitions and strong organic growth. EBITDA surged 60% to $8.3M with margins expanding 310bp to 17.1%, while NPAT increased 61.7% to $4.7M. The company maintains a strong balance sheet with $15.2M cash and no debt, positioning it well for continued growth despite not paying dividends. Key points: Record revenue of $48.2M up 30.7% with strong organic growth of 10% in ANZ and 37% in North America; EBITDA margins expanded significantly by 310bp to 17.1% demonstrating operational leverage and scale benefits; Strong cash generation of $9.2M from operations while maintaining debt-free balance sheet with $15.2M cash

Get real-time alerts for AHC

Receive AI-powered earnings summaries and instant notifications when Austco Healthcare Limited releases results.

Register Free